Clinical Value and Regulatory Mechanism of miR-767-5p in Colorectal Cancer
Folia Biologica · 2025
DOI: 10.14712/fb2025071010018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Biologica, 2025. Verfasst von Ping Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Minimally Invasive Surgery Center, Second People's Hospital of Hunan Province (Hunan Brain Hospital), Changsha, China. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The poor prognosis of colorectal cancer (CRC) contributes to a yearly increase in CRC mortality, while microRNAs (miRNAs) were found to play a regulatory function in diversiform cancers, including CRC. The objective of this research was to evaluate the clinical value and possible regulatory mechanisms of miR-767-5p in CRC. The expression level of miR-767-5p in CRC tissues and cells was examined. The Kaplan-Meier curve was utilized to analyse the function of miR-767-5p in CRC prognosis. The independent prognostic factors in CRC were assessed by a multivariate COX regression analysis. Additionally, the regulatory mechanism of miR-767-5p in CRC was determined through an in vitro cell experiment. The miR-767-5p expression was down-regulated in CRC tumour tissues and CRC cells. Indicators such as tumour differentiation, TNM, LNM and miR-767-5p were identified as independent prognostic factors for a poor CRC prognosis. The regulatory relationship between miR-767-5p and nuclear factor I A ( NFIA ) was verified by the dual-luciferase reporter assay, and the NFIA expression level was significantly suppressed by over-expressed miR-767-5p. The proliferation, migration and invasion of CRC cells were inhibited by over-expressing miR-767-5p, while the inhibition effect could be reversed by over-expressing NFIA . The over-expressed miR-767-5p could serve as a tumour suppressor to inhibit the progression of CRC by suppressing the expression level of NFIA .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Minimally Invasive Surgery Center, Second People's Hospital of Hunan Province (Hunan Brain Hospital), Changsha, China.
- Department of Oncology, No. 971 Navy Hospital of the Chinese People's Liberation Army, Qingdao, China.
- Department of Nursing, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, China.
- Department of Hospice, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, China.
- Department of Nursing, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, China. yilili_xiangya@163.com.
- Department of Pathology, Affiliated Hospital of Hebei University, Baoding, China. Liangyuemianhb@163.com.
Zitieren
APA
Lin, P., Qin, X., Yi, C., Jiang, M., Yi, L., & Liang, Y. (2025). Clinical Value and Regulatory Mechanism of miR-767-5p in Colorectal Cancer. Folia Biologica. https://doi.org/10.14712/fb2025071010018
Vancouver
Lin P, Qin X, Yi C, Jiang M, Yi L, Liang Y. Clinical Value and Regulatory Mechanism of miR-767-5p in Colorectal Cancer. Folia Biologica. 2025. doi:10.14712/fb2025071010018
BibTeX
@article{Lin2025,
author = {Lin, Ping and Qin, Xiuju and Yi, Caiyun and Jiang, Man and Yi, Lili and Liang, Yuemian},
title = {Clinical Value and Regulatory Mechanism of miR-767-5p in Colorectal Cancer},
journal = {Folia Biologica},
year = {2025},
doi = {10.14712/fb2025071010018}
}
EUVIMED